The company is no longer just a drugstore chain; it has expanded its "minute clinic" to more than 900 locations in 29 states. The move was announced on Sept. 3, when the company stopped selling tobacco products at its 7,700 stores, a month ahead of schedule. CVS Health is on a path to gain the reputation of treating patients and helping smokers quit the habit.
Read More: 10 Stocks George Soros Is Buying in 2014
Shares of Walgreen stalled after they set an all-time intraday high at $76.39 on June 19. Since then, it's been a choppy ride for this stock. Investors were expecting that the company would relocate to Switzerland in a tax-inversion strategy after completing its acquisition of Alliance Boots, a Swiss company that operates health and beauty stores in Europe.
But on Aug. 5, Walgreen announced it would keep its headquarters in the U.S. On Aug. 6, the stock gapped below its 200-day simple moving average, trading as low as $57.75 that day.
Walgreen ($60.18) will report its quarterly results before the opening bell on Tuesday, and analysts expect the drugstore giant to post earnings of 75 cents per share. If you remain an investor in this stock, the upside on a positive reaction should be limited to the 200-day SMA, which is now at $65.59.
Read More: How Healthy Are CVS and Walgreen?
If you visit your local CVS/pharmacy, you may be impressed by the "minute clinic." The cllinics are at the back of stores, next to the in-store pharmacies. There's seating in the waiting area and private rooms for patients. In between is a convenient and easy-to-use data entry terminal. Fill out the online forms, and you are ready to see a nurse practitioner.